Microbial and viral pathogens in colorectal cancer

The Lancet Oncology

Volumn 12, Issue 5, 2011, Pages 504-512

  Collins, Danielle ^a   Hogan, Aisling M ^a   Winter, Desmond C ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; EPITHELIUM; HOST PATHOGEN INTERACTION; HUMAN; HYPOTHESIS; MICROORGANISM; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NOTE; PRIORITY JOURNAL; STOMACH CARCINOMA; VIRUS INFECTION;

ALPHAPAPILLOMAVIRUS; BACTERIAL INFECTIONS; BACTERIAL TOXINS; BACTEROIDES; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYTOMEGALOVIRUS; DNA DAMAGE; ESCHERICHIA COLI; FREE RADICALS; HELICOBACTER PYLORI; HERPESVIRUS 4, HUMAN; HUMANS; INFLAMMATION; JC VIRUS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; STREPTOCOCCUS BOVIS; VIRUS DISEASES;

EID: 79955466291     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70186-8     Document Type: Note

References (110)

1. Sandler RS Epidemiology and risk factors for colorectal cancer. Gastroenterol Clin North Am 1996, 25:717-735.
2. Alexander DD, Cushing CA, Lowe KA, Sceurman B, Roberts MA Meta-analysis of animal fat or animal protein intake and colorectal cancer. Am J Clin Nutr 2009, 89:1402-1409.
3. Hutchinson E Alfred Knudson and his two-hit hypothesis. Lancet Oncol 2001, 2:642-645.
4. Brower V Connecting viruses to cancer: how research moves from association to causation. J Natl Cancer Inst 2004, 96:256-257.
5. Takada K Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000, 53:255-261.
6. Søreide K, Nedrebø BS, Knapp JC, Glomsaker TB, Søreide JA, Kørner H Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist. Surg Oncol 2009, 18:31-50.
7. Slattery ML, Curtin K, Wolff RK, et al. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum 2009, 52:1304-1311.
8. Shen L, Toyota M, Kondo Y, et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA 2007, 104:18654-18659.
9. Samowitz WS, Albertsen H, Sweeney C, et al. Association of smoking, CpG Island Methylator Phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 2006, 98:1731-1738.
10. Slattery ML, Anderson K, Curtin K, et al. Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 2001, 483:73-81.
11. Waisberg J, Cde O Matheus, Pimenta J Infectious endocarditis from Streptococcus bovis associated with colonic carcinoma: case report and literature review. Arq Gastroenterol 2002, 39:177-180.
12. Gold JS, Bayar S, Salem RR Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004, 139:760-765.
13. Alazmi W, Bustamante M, O'Loughlin C, Gonzalez J, Raskin JB The association of Streptococcus bovis bacteremia and gastrointestinal diseases: a retrospective analysis. Dig Dis Sci 2006, 51:732-736.
14. Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 1977, 297:800-802.
15. Dubrow R, Edberg S, Wikfors E, et al. Fecal carriage of Streptococcus bovis and colorectal adenomas. Gastroenterology 1991, 101:721-725.
16. Norfleet RG, Mitchell PD Streptococcus bovis does not selectively colonize colorectal cancer and polyps. J Clin Gastroenterol 1993, 17:25-28.
17. Burns CA, McCaughey R, Lauter CB The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. Am J Gastroenterol 1985, 80:42-46.
18. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006, 11:75-80.
19. Grahn N, Hmani-Aifa M, Fransen K, Soderkvist P, Monstein HJ Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol 2005, 54:1031-1035.
20. Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship?. World J Surg Oncol 2007, 5:51.
21. Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One 2009, 4:e5517.
22. Swidsinski A, Khilkin M, Kerjaschki D, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998, 115:281-286.
23. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004, 127:80-93.
24. Toprak NU, Yagci A, Gulluoglu BM, et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 12: 782-86.
25. de Kok TM, Pachen D, van Iersel ML, et al. Case-control study on fecapentaene excretion and adenomatous polyps in the colon and rectum. J Natl Cancer Inst 1993, 85:1241-1244.
26. Schiffman MH, Van Tassell RL, Robinson A, et al. Case-control study colorectal cancer and fecapentaene excretion. Cancer Res 1989, 49:1322-1326.
27. Scanlan PD, Shanahan F, Marchesi JR Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals. FEMS Microbiol Ecol 2009, 69:213-221.
28. Balamurugan R, Rajendiran E, George S, Samuel GV, Ramakrishna BS Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 2008, 23:1298-1303.
29. Hussain SP, Hofseth LJ, Harris CC Radical causes of cancer. Nat Rev Cancer 2003, 276:276-285.
30. Marnett LJ Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361-370.
31. Gupta RA, DuBois RN Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001, 1:11-21.
32. Peek RM, Crabtree JE Helicobacter infection and gastric neoplasia. J Pathol 2006, 208:233-248. 2006.
33. Haghjoo E, Galán JE Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc Natl Acad Sci USA 2004, 101:4614-4619.
34. Wu S, Morin PJ, Maouyo D, Sears CL Bacteroides fragilis enterotoxin induces c-myc expression and cellular proliferation. Gastroenterol 2003, 124:392-400.
35. Nougayrède JP, Taieb F, De Rycke J, Oswald E Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol 2005, 13:103-110.
36. Lacerda HM, Pullinger GD, Lax AJ, Rozengurt E Cytotoxic necrotizing factor 1 from Escherichia coli and dermonecrotic toxin from Bordetella bronchiseptica induce p21(rho)-dependent tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 cells. J Biol Chem 1997, 272:9587-9596.
37. Wu S, Morin PJ, Maouyo D, Sears CL Bacteroides fragilis enterotoxin induces c-myc expression and cellular proliferation. Gastroenterol 2003, 124:392-400.
38. Cover TL, Blanke SR Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nature Rev Microbiol 2005, 3:320-332.
39. Blair IA Lipid hydroperoxide-mediated DNA damage. Exp Gerontol 2001, 36:1473-1481.
40. Owen RW, Spiegelhalder B, Bartsch H Generation of reactive oxygen species by the faecal matrix. Gut 2000, 46:225-232.
41. Huycke MM, Moore DR In vivo production of hydroxyl radical by Enterococcus faecalis colonizing the intestinal tract using aromatic hydroxylation. Free Radic Biol Med 2002, 33:818-826.
42. Huycke MM, Abrams V, Moore DR Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 2002, 23:529-536.
43. Attene-Ramos MS, Wagner ED, Plewa MJ, Gaskins HR Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res 2006, 4:9-14.
44. Wang D, DuBois RN Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett 2008, 267:197-203.
45. Biarc J, Nguyen IS, Pini A, et al. Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis 2004, 25:1477-1484.
46. Ellmerich S, Schöller M, Duranton B, et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 2000, 21:753-756.
47. Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009, 15:1016-1022.
48. Hooper LV, Gordon JI Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118.
49. McCole DF, Barrett KE Varied role of the gut epithelium in mucosal homeostasis. Curr Opin Gastroenterol 2007, 23:647-654.
50. Erdman SE, Poutahidis T Roles for inflammation and regulatory T cells in colon cancer. Toxicol Pathol 2010, 38:76-87.
51. Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003, 9:606-612.
52. Jung WT, Li MS, Goel A, Boland CR JC virus T-antigen expression in sporadic adenomatous polyps of the colon. Cancer 2008, 112:1028-1036.
53. Hori R, Murai Y, Tsuneyama K, et al. Detection of JC virus DNA sequences in colorectal cancers in Japan. Virchows Arch 2005, 447:723-730.
54. Theodoropoulos G, Panoussopoulos D, Papaconstantinou I, et al. Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum 2005, 48:86-91.
55. Laghi L, Randolph AE, Chauhan DP, et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci USA 1999, 96:7484-7489.
56. Yuen ST, Chung LP, Leung SY, et al. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J Surgical Pathol 1994, 18:1158-1163.
57. Grinstein S, Preciado MV, Gattuso P, et al. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 2002, 62:4876-4878.
58. Song LB, Zhang X, Zhang CQ, et al. Infection of Epstein-Barr virus in colorectal cancer in Chinese. Ai Zheng 2006, 25:1356-1360.
59. Harkins L, Volk AL, Samanta M, et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002, 360:1557-1563.
60. Hashiro GM, Horikami S, Loh PC Cytomegalovirus isolations from cell cultures of human adenocarcinomas of the colon. Intervirology 1979, 12:84-88.
61. Knösel T, Schewe C, Dietel M, Petersen I Cytomegalovirus is not associated with progression and metastasis of colorectal cancer. Cancer Lett 2004, 211:243-247.
62. Bender C, Zipeto D, Bidoia C, et al. Analysis of colorectal cancers for human cytomegalovirus presence. Infect Agent Cancer 2009, 4:6.
63. Hart H, Neill WA, Norval M Lack of association of cytomegalovirus with adenocarcinoma of the colon. Gut 1982, 23:21-30.
64. Shah KV, Daniel RW, Simons JW, Vogelstein B Investigation of colon cancers for human papillomavirus genomic sequences by polymerase chain reaction. J Surg Oncol 1992, 51:5-7.
65. Strickler HD, Schiffman MH, Shah KV, et al. A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev 1998, 7:305-313.
66. Kirgan D, Manalo P, Hall M, McGregor B Association of human papillomavirus and colon neoplasms. Arch Surg 1990, 125:862-865.
67. Cheng JY, Sheu LF, Meng CL, Lee WH, Lin JC Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction. Gut 1995, 37:87-90.
68. Salepci T, Yazici H, Dane F, et al. Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients. J BUON 2009, 14:495-499.
69. McGregor B, Byrne P, Kirgan D, Albright J, Manalo P, Hall M Confirmation of the association of human papillomavirus with human colon cancer. Am J Surg 1993, 166:738-740.
70. Lee YM, Leu SY, Chiang H, Fung CP, Liu WT Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 2001, 34:87-91.
71. Bodaghi S, Yamanegi K, Xiao SY, da Costa M, Palefski JM, Zheng ZM Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005, 11:2862-2867.
72. Damin DC, Caetano MB, Rosito MA, et al. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 2007, 33:569-574.
73. Gornick MC, Castellsague X, Sanchez G, et al. Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control 2010, 21:737-743.
74. Brichacek B, Hirsch I, Zavadova H, et al. Absence of cytomegalovirus DNA from adenocarcinoma of the colon. Intervirology 1980, 14:223-227.
75. Evans AS, Mueller NE Viruses and cancer: causal associations. Ann Epidemiol 1990, 1:71-92.
76. Muñoz N Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000, 19:1-5.
77. Ricciardi R, Ghabreau L, Yasmeen A, Darnel AD, Akil N, Al Moustafa A Role of E6/E7 onco-proteins of high-risk human papillomaviruses in human colorectal carcinogenesis. Cell Cycle 2009, 8:1964-1965.
78. Butel JS Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000, 21:405-426.
79. Xiong A, Clarke-Katzenberg RH, Valenzuela G, Izumi KM, Millan MT Epstein-Barr virus latent membrane protein 1 activates nuclear factor-kappa B in human endothelial cells and inhibits apoptosis. Transplantation 2004, 78:41-49.
80. de Oliveira D Elgui DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett 2007, 247:182-196.
81. Miao Y, Everly JJ, Gross TG, et al. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation 2009, 87:1347-1359.
82. Noble CJ Carriage of group D streptococci in the human bowel. J Clin Pathol 1978, 31:1182-1186.
83. Roses DF, Richman H, Localio SA Bacterial endocarditis associated with colorectal carcinoma. Ann Surg 1974, 179:190-191.
84. Tjalsma H, Scholler-Guinard M, Lasonder E, Ruers TJ, Willems HL, Swinkels DW Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer 2006, 119:2127-2135.
85. Darjee R, Gibb AP Serological investigation into the association between Streptococcus bovis and colonic cancer. J Clin Pathol 1993, 46:1116-1119.
86. Agostini HT, Yanagihara R, Davis V, Ryschkewitsch CF, Stoner GL Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration. Proc Natl Acad Sci USA 1997, 94:14542-14546.
87. Bofill-Mas S, Formiga-Cruz M, Casares P Clemente, Calafell F, Girones R Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001, 75:10290-10299.
88. Asa SL, Lee YC, Drucker DJ Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene. Virchows Arch 1996, 427:595-606.
89. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS The establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci USA 1993, 90:587-591.
90. Nosho K, Shima K, Kure S, et al. JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. Neoplasia 2009, 11:87-95.
91. Enam S, Del Valle L, Lara C, et al. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 2002, 62:7093-7101.
92. Ricciardiello L, Baglioni M, Giovannini C, et al. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 2003, 63:7256-7262.
93. Young LS, Rickinson AB Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757-768.
94. Wong M, Chung L, Yuen S, et al. In situ detection of Epstein-Barr virus in non-small cell lung carcinomas. J Pathol 1995, 177:233-240.
95. Bonnet M, Guinebretiere J, Kremmer E, Grunewald V, Benhamou E, Contesso G Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999, 91:1376-1381.
96. Boldogh I, AbuBakar S, Deng CZ, Albrecht T Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J Virol 1991, 65:1568-1571.
97. Jault FM, Jault JM, Ruchti F, et al. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 1995, 69:6697-6704.
98. Zhu H, Shen Y, Shenk T Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 1995, 69:7960-7970.
99. Zhu H, Cong JP, Mamtora G, et al. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci USA 1998, 95:14470-14475.
100. Jarvis MA, Wang CE, Meyers HL, et al. Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol 1999, 73:4552-4560.
101. Adani GL, Baccarani U, Lorenzin D, et al. De novo gastrointestinal tumours after renal transplantation: role of CMV and EBV viruses. Clin Transplant 2006, 20:457-460.
102. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003, 89:1221-1227.
103. Brunner FP, Landais P, Selwood NH Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association. Nephrol Dial Transplant 1995, 10:74-80.
104. Johnson EE, Leverson GE, Pirsch JD, Heise CP A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J Gastrointest Surg 2007, 11:272-279.
105. Stewart T, Henderson R, Grayson H, Opelz G Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed. Clin Cancer Res 1997, 3:51-55.
106. Selgrad M, Koornstra JJ, Fini L, et al. JC virus infection in colorectal neoplasia that develops after liver transplantation. Clin Cancer Res 2008, 14:6717-6721.
107. Evans AS Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 1976, 49:175-195.
108. Hill AB Environment and disease: association or causation?. Proc R Soc Med 1965, 58:295-300.
109. Parsonnet J Bacterial infection as a cause of cancer. Environ Health Perspect 1995, 103:263-268.
110. Butel JS Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000, 21:405-426.